Vnitr Lek 2013, 59(10):874-875

Infekční endokarditida u intravenózních toxikomanů - editorial

P. Gregor
Kardiocentrum - III. interní - kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC

Received: March 20, 2013; Published: October 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor P. Infekční endokarditida u intravenózních toxikomanů - editorial. Vnitr Lek. 2013;59(10):874-875.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chirouze C, Hoen B, Duval X. Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention? Eur J Clin Microbiol Infect Dis 2012; 31: 2089-2095. Go to original source... Go to PubMed...
    2. Gregor P. Výskyt infekční endokarditidy a některé problémy její diagnostiky - editorial. Vnitř Lék 2011; 57: 130-131. Go to PubMed...
    3. Beneš J, Baloun R, Džupová O. Endokarditidy 2007. Výsledky multicentrické studie o výskytu a vlastnostech infekční endokarditidy. Vnitř Lék 2011; 57: 147-154. Go to PubMed...
    4. Rataj O, Martinkovičová L, Šetina M. Infekční endokarditida na trikuspidální chlopni u intravenózní narkomanky. Vnitř Lék 2013; 59: 938-941.
    5. Beneš J, Gregor P, Mokráček A. Infekční endokarditida: doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 49: K157-K171.
    6. Wilson LE, Thomas DL, Astemborski J et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis 2002; 185: 1761-1766. Go to original source... Go to PubMed...
    7. Rabkin DG, Mokadam NA, Miller DW et al. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg 2012; 93: 51-58. Go to original source... Go to PubMed...
    8. DeRosa FG, Cicalini S, Canta F et al. Infective endocarditis in intravenous drug users from Italy: The increasing importance in HIV-infected patiens. Infection 2007; 35: 154-160. Go to original source... Go to PubMed...
    9. Sousa C, Botelho C, Rodrigues D et al. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis 2012; 31: 2905-2910. Go to original source... Go to PubMed...
    10. Carozza A, De Santo LS, Romano G et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis 2006; 15: 125-131. Go to PubMed...
    11. Miró JM, Moreno A, Mestres CA. Infective endocarditis in intravenous drug abusers. Curr Infect Dis Rep 2003; 5: 307-316. Go to original source... Go to PubMed...
    12. Daas H, Abuhmaid F, Zervos M. Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. J Med Case Rep 2009; 3: 6598. Go to original source... Go to PubMed...
    13. Adler AG, Blumberg EA, Schwarz DA et al. Seven-pathogen tricuspid endocarditis in an intravenous drug abuser. Pitffals in laboratory diagnosis. Chest 1991: 99: 490-491. Go to original source... Go to PubMed...
    14. Saydain G, Singh J, Dalal B et al. Outcome of patients with injection drug use-associated endocarditis admitted to an intensive care unit. J Crit Care 2010; 25: 248-253. Go to original source... Go to PubMed...
    15. Jain V, Yang MH, Kovacicova-Lezcano G et al. Infective endocarditis in an urban medical center: association of individual drugs with valvular involvement. J Infect 2008; 57: 132-138. Go to original source... Go to PubMed...
    16. McGiffin DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995; 7: 25-31.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.